Millipore Sigma Vibrant Logo

SGW1A47FF3 Optiscale® Capsule Polysep® II 1.0/0.2/0.1 µm 3/4 in. TC/TC

View Products on Sigmaaldrich.com
SGW1A47FF3
3  
正在检索价格......
无法检索价格。
最小订购数量为倍数
Maximum Quantity is
以订单确认为准 更多信息
您节约了 ()。
 
Request Pricing
目前缺货
目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余:另行通知
      其余:另行通知
      另行通知
      联系客户服务
      Contact Customer Service

       

      联系客户服务

      概述

      Replacement Information
      Description
      Catalogue NumberSGW1A47FF3
      Trade Name
      • OptiScale®
      DescriptionOptiscale® Capsule Polysep® II 1.0/0.2/0.1 µm 3/4 in. TC/TC
      References
      Product Information
      FormatTriple Layer
      Device ConfigurationCapsule
      Connections, Inlet/OutletSanitary Flange/Sanitary Flange
      Good Manufacturing PracticesThese products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.
      Quality LevelMQ400
      Applications
      Biological Information
      MediaPolysep™ II
      Physicochemical Information
      Pore Size1.0 / 0.2 / 0.1 µm
      Inlet ConnectionSanitary Flange
      Outlet ConnectionSanitary Flange
      Indirect Food AdditiveAll component materials meet the FDA Indirect Food Additive requirements cited in 21 CFR 177-182.
      Maximum Inlet Pressure (psig)80 psig
      Maximum Inlet Temperature25 °C
      Dimensions
      Inlet Connection Diameter3/4 in.
      Nominal Pore Size1.0 / 0.2 / 0.1 µm
      Outlet Connection Diameter3/4 in.
      Materials Information
      Chemistry
      • Borosilicate Glass Fiber (BGF)
      • Mixed Cellulose Esters (MCE)
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Packaging Information
      Material Size3
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      SGW1A47FF3 04053252713712

      相关产品和应用

      相关产品,按下列排序: Brand Facete

      种类

      Biopharmaceutical Manufacturing > Drug Substance > Bioburden Reduction/Particulate Control > Membrane based > Polysep II
      Small Molecule Pharmaceuticals > API Synthesis > Bioburden Reduction/Particulate Control > Membrane based > Polysep II
      Small Molecule Pharmaceuticals > Bulk API > Bioburden Reduction/Particulate Control > Membrane based > Polysep II
      Biopharmaceutical Manufacturing > Upstream Processing > Bioburden Reduction / Particulate Control > Membrane based > Polysep II
      Biopharmaceutical Manufacturing > Downstream Processing > Bioburden Reduction/Particulate Control > Membrane based > Polysep II
      Biopharmaceutical Manufacturing > Harvest > Bioburden Reduction / Particulate Control > Membrane based > Polysep II
      Small Molecule Pharmaceuticals > Purification of Pharm Drugs > Bioburden Reduction/Particulate Control > Membrane based > Polysep II
      Biopharmaceutical Manufacturing > Formulation > Bioburden Reduction/Particulate Control > Membrane based > Polysep II